Skip to main content
SpringerLink
Log in

Hypertensive Disorders of Pregnancy

  • Chapter
  • First Online:
Medical Management of the Pregnant Patient

Abstract

Hypertensive disorders in pregnancy are a major cause of both maternal and fetal morbidity and mortality and account for approximately one quarter of all antenatal admissions to the hospital [1]. The spectrum of hypertensive disorders in pregnancy includes preexisting hypertension, new-onset hypertension in pregnancy, as well as hypertension that may occur de novo in the postpartum period. Challenges in the management of hypertension in pregnancy include choosing when to use antihypertensive medication, goals of antihypertensive therapy, and which drugs to use. Recent data also show that hypertensive disorders of pregnancy are associated with long-term cardiovascular risks in women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009;122(10):890–5.

    Article  PubMed  Google Scholar 

  2. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31.

    Google Scholar 

  3. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41(3):437–45.

    Article  CAS  PubMed  Google Scholar 

  4. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. 1984;150(7):831–5.

    Article  CAS  PubMed  Google Scholar 

  5. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002;100(2):369–77.

    Article  PubMed  Google Scholar 

  6. Zetterstrom K, Lindeberg SN, Haglund B, Hanson U. Maternal complications in women with chronic hypertension: a population-based cohort study. Acta Obstet Gynecol Scand. 2005;84(5):419–24.

    Article  PubMed  Google Scholar 

  7. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Callaway LK, Lawlor DA, O’Callaghan M, Williams GM, Najman JM, McIntyre HD. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am J Obstet Gynecol. 2007;197(5):492 e1–7.

    Google Scholar 

  9. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia Lancet. 2010;376(9741):631–44.

    Article  Google Scholar 

  10. Berg CJ, An LC, Kirch M, Guo H, Thomas JL, Patten CA, et al. Failure to report attempts to quit smoking. Addict Behav. 2010;35(10):900–4.

    Article  PubMed  Google Scholar 

  11. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856–69.

    Article  PubMed  Google Scholar 

  12. Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med. 2007;52(11):1046–51.

    PubMed  Google Scholar 

  13. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamins in Pre-eclampsia Trial C. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006;367(9517):1145–54.

    Article  CAS  PubMed  Google Scholar 

  14. Engeland A, Bjorge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, et al. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. Eur J Epidemiol. 2011;26(2):157–63.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American heart association. Circulation. 2011;123(11):1243–62.

    Article  PubMed Central  PubMed  Google Scholar 

  16. European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97.

    Google Scholar 

  17. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007;1, CD002252.

    PubMed  Google Scholar 

  18. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can. 2002;24(12):941–5.

    Google Scholar 

  19. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. Obstet Gynecol. 2012;119(2 Pt 1):396–407.

    Google Scholar 

  20. Vanek M, Sheiner E, Levy A, Mazor M. Chronic hypertension and the risk for adverse pregnancy outcome after superimposed pre-eclampsia. Int J Gynaecol Obstet. 2004;86(1):7–11.

    Article  CAS  PubMed  Google Scholar 

  21. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol. 2009;49(3):242–6.

    Article  PubMed  Google Scholar 

  22. Magee LA, Helewa M, Moutquin JM, von Dadelszen P, Hypertension Guideline C. Strategic training initiative in research in the reproductive health sciences S. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(3 Suppl):S1–48.

    PubMed  Google Scholar 

  23. National Collaborating Centre for Women's and Children’s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: RCOG Press; 2010.

    Google Scholar 

  24. van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol. 2006;195(3):723–8.

    Article  PubMed  Google Scholar 

  25. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990;162(4):960–6. discussion 6-7.

    Article  CAS  PubMed  Google Scholar 

  26. Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol. 1987;70(3 Pt 1):323–7.

    CAS  PubMed  Google Scholar 

  27. Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012;206(6):470–5.

    Article  PubMed  Google Scholar 

  28. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362(14):1282–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Ray JG, Burrows RF, Burrows EA, Vermeulen MJMOSHIP. McMaster outcome study of hypertension in pregnancy. Early Hum Dev. 2001;64(2):129–43.

    Article  CAS  PubMed  Google Scholar 

  30. Podymow T, August P. Antihypertensive drugs in pregnancy. Semin Nephrol. 2011;31(1):70–85.

    Article  CAS  PubMed  Google Scholar 

  31. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Br J Obstet Gynaecol. 1988;95(9):868–76.

    Article  CAS  PubMed  Google Scholar 

  32. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443–51.

    Article  CAS  PubMed  Google Scholar 

  33. Pickles CJ, Symonds EM, Broughton PF. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989;96(1):38–43.

    Article  CAS  PubMed  Google Scholar 

  34. Pell JP, Smith GC, Walsh D. Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. Am J Epidemiol. 2004;159(4):336–42.

    Article  PubMed  Google Scholar 

  35. Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004;190(5):1464–6.

    Article  PubMed  Google Scholar 

  36. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56(1):166–71.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Martin Jr JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105(2):246–54.

    Article  PubMed  Google Scholar 

  38. Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol. 1996;174(3):823–8.

    Article  CAS  PubMed  Google Scholar 

  39. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955–60.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994;343(8898):619–29.

    Google Scholar 

  41. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, Group PC. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369(9575):1791–8.

    Article  CAS  PubMed  Google Scholar 

  42. Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2006;3, CD001059.

    PubMed  Google Scholar 

  43. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2010;4(2):68–78.

    Article  CAS  PubMed  Google Scholar 

  44. Lawler J, Osman M, Shelton JA, Yeh J. Population-based analysis of hypertensive disorders in pregnancy. Hypertens Pregnancy. 2007;26(1):67–76.

    Article  PubMed  Google Scholar 

  45. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323(7323):1213–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Saftlas AF, Logsden-Sackett N, Wang W, Woolson R, Bracken MB. Work, leisure-time physical activity, and risk of preeclampsia and gestational hypertension. Am J Epidemiol. 2004;160(8):758–65.

    Article  PubMed  Google Scholar 

  47. Sorensen TK, Williams MA, Lee IM, Dashow EE, Thompson ML, Luthy DA. Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension. 2003;41(6):1273–80.

    Article  CAS  PubMed  Google Scholar 

  48. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366(9499):1797–803.

    Article  PubMed  Google Scholar 

  49. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53(6):944–51.

    Article  CAS  PubMed  Google Scholar 

  51. Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens. 1999;12(6):541–7.

    Article  CAS  PubMed  Google Scholar 

  52. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008;112(2 Pt 1):359–72.

    Article  PubMed  Google Scholar 

  53. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325(7356):157–60.

    Article  PubMed Central  PubMed  Google Scholar 

  54. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51(4):1002–9.

    Article  CAS  PubMed  Google Scholar 

  55. Berks D, Steegers EA, Molas M, Visser W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol. 2009;114(6):1307–14.

    Article  PubMed  Google Scholar 

  56. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–9.

    Article  CAS  PubMed  Google Scholar 

  57. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Obstetric Medicine, Women’s Medicine Collaborative, The Miriam Hospital, Providence, RI, USA

    Margaret A. Miller M.D.

  2. The Warren Alpert Medical School at Brown University, Providence, RI, USA

    Margaret A. Miller M.D.

  3. Women’s Medicine Collaborative, The Miriam Hospital, Providence, RI, USA

    Marshall Carpenter M.D.

  4. Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, MA, USA

    Marshall Carpenter M.D.

Authors
  1. Margaret A. Miller M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marshall Carpenter M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. SVP Women’s Services and Clinical Integration, Lifespan Corporation, Professor and Vice Chair of Medicine Director of Obstetric Medicine, Alpert Medical School at Brown University, Providence, Rhode Island, USA

    Karen Rosene-Montella

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Miller, M.A., Carpenter, M. (2015). Hypertensive Disorders of Pregnancy. In: Rosene-Montella, K. (eds) Medical Management of the Pregnant Patient. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1244-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1244-1_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1243-4

  • Online ISBN: 978-1-4614-1244-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation